Subscriber Login
E-Mail
Password
HOME
RESEARCH
Market Analysis and Trends
Strategy Operations and Management
Regulation Compliance and Risk
ADVISORY
Custom Research
Benchmarking
Speaking Engagements
PERIODICALS
Laboratory Industry Report
G2 Compliance Report
National Intelligence Report
Diagnostic Testing and Technology Report
EVENTS
Live Events
Webinars
Forums
ABOUT
Team
History
Logo
Careers
CONTACT
FREE e-zine for diagnostics pros.
Subscribe now
to this weekly email featuring G2's proprietary findings.
Upcoming G2 Events
Lab Outreach 2012
June 6-8, 2012
Paris Las Vegas
Las Vegas, NV
Lab Institute 2012
October 10-12, 2012
Crystal Gateway Marriot
Arlington, VA
Lab Leaders' Summit 2012
November 14, 2012
Union League Club of New York
New York, NY
G2 Research
Medicare Payment and Policy Guide for Laboratory and Pathology Services 2012
Laboratory Industry Strategic Outlook: Niche/Specialty Markets
U.S. Laboratory Reference Testing - Market Profile & Pricing Trends 2010
Lab Industry Analysis 2010: Test Volumes, Revenues, and Category Leaders
Diagnostics Market Analysis and Trends
Research
Lab Industry Strategic Outlook 2011: Market Trends & Analysis
Lab Industry Analysis 2010: Test Volumes, Revenues, and Category Leaders
U.S. Laboratory Reference Testing - Market Profile & Pricing Trends 2010
Events
Lab Institute 2012 - 30th Anniversary!
October 10-12, 2012 - Arlington, VA
Lab Leaders' Summit 2012
November 14, 2012 - New York, NY
Features & Analysis
»
Saliva Tests May Be Moving Toward Clinical Adoption, Though Verdict Still Out on Noninvasive Diagnostics
The combination of patient preference for nonpainful, minimally invasive testing options and recognition that the convenience of rapid, point-of-care testing may facilitate earlier diagnosis of many chronic conditions is driving the push toward clinical adoption of saliva-based diagnostics tests.
more…
Copyright © 2012 Kennedy Information, LLC
Comment to the Editor
Email article to a friend
Laboratory Business Strategy and Operations
Research
Creating a Value-Driven Laboratory: Opportunities in the New Marketplace
How to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations
Health Care Market Reforms: Implications and Prescriptions for Laboratories
Sales Compensation in the Laboratory Industry: Incentives, Plans and Strategies
Events
Lab Outreach 2012
June 6-8, 2012 - Las Vegas, NV
Pathology Institute 2012 - CD Recordings Available Now
February 9-10, 2012 - Fort Lauderdale, FL
Webinar: The End of the Pathology Grandfather: Strategies for Negotiating TC Payments with Hospitals
Thursday, May 31, 2012 2:00 p.m. - 3:30 p.m. ET
Webinar: The Importance of Laboratory Internal Audits
Thursday, June 21, 2012 2:00 p.m. - 3:30 p.m. ET
Features & Analysis
»
MDx Health Establishes California Lab, Boosts Revenue in Fourth Quarter 2011
MDxHealth (Liege, Belgium), which recently established a clinical laboratory in Irvine, Calif., reported that total revenues for the fourth quarter of 2011 increased by 48 percent to 9 million euros from 6 million euros during the same period in 2010. The revenue increase was attributable to the company’s pharmaco-diagnostic business.
more…
Copyright © 2012 Kennedy Information, LLC
Comment to the Editor
Email article to a friend
Diagnostics Regulation, Compliance and Risk
Reference
Medicare Payment and Policy Guide for Laboratory and Pathology Services 2012
CLIA Compliance: The Essential Reference for the Clinical Laboratory, 3rd Edition
Features & Analysis
»
ACLA Calls on Congress for Relief From Medicare Lab Fee Cuts
In a March 6 letter to House Majority Leader John Boehner (R-Ohio) and Senate Majority Leader Harry Reid (D-Nev.), the American Clinical Laboratory Association (ACLA) asks that the current level of cuts to Medicare lab fees be revisited and relief provided.
more…
Copyright © 2012 Kennedy Information, LLC
Comment to the Editor
Email article to a friend
G2's FREE, weekly email
gives you access to G2 market analysis, regulatory changes, M&A activity, leadership moves and more on the diagnostics industry. Recent articles include:
»
Sequencing Superior to Flow Cytometry for Detecting Cancer Relapse, Study Finds
The first use of high-throughput sequencing to detect minimal residual disease in a clinical trial setting found it to be at least 20 times more sensitive than flow cytometry in detecting the condition, a major predictor of cancer relapse.
more…
»
Industry Executive Move: SUNY - Upstate Medical University
Robert Corona Jr., D.O., has been named the chair of the Department of Pathology at Upstate Medical University, State University of New York.
more…
»
Managed Care Pressures Putting the Squeeze on Labs
Increasing pressure from health plans is putting the squeeze on local and regional labs, which are finding it more and more difficult to compete with the low prices offered by the nation’s two largest lab companies, Quest and LabCorp.
more…
More
Insider
G2's FREE, daily email service
brings you up-to-the-minute lab and diagnostics industry news from from across the spectrum of providers.
Advertising
|
Privacy
|
Sitemap
G2 Intelligence © 2012 Kennedy Information, LLC
A Bloomberg BNA Business
Phone: 800.401.5937 or +1.973.718.4700
All Rights Reserved.
|
»